baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Aurinia Pharmaceuticals Inc/ CA05156V1022 /

1/10/2025 10:00:00 PM	Chg. -0.2700	Volume	Bid1:24:44 PM	Ask1:24:44 PM	High	Low
8.0700USD	-3.24%	2.42 mill. Turnover: 16.8 mill.	7.8500Bid Size: 100	8.4600Ask Size: 200	8.2700	7.7900

GlobeNewswire 6/13/2024 Rheumatologists' Aggressive Approach to SLE Treatment Targets Specific Patient Types with Biologics

GlobeNewswire 3/25/2024 Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Director...

GlobeNewswire 3/18/2024 American Kidney Fund Convenes Nation’s Kidney Community for 2024 Kidney Action Week™ March 18-22

GlobeNewswire 3/15/2024 American Kidney Fund Announces 2024 Class of Corporate Members Providing Support in the Fight Agains...

GlobeNewswire 2/22/2024 Dr. Robert Huizinga Elected to the Kane Biotech Board and Appointed Executive Chair

GlobeNewswire 1/18/2024 Kane Biotech Announces Special Meeting of Shareholders

GlobeNewswire 11/8/2023 Spherix Global Insights Amplifies the Lupus Patient Voice, Highlighting the Lengthy and Challenging ...

Newsfile Corp 5/18/2022 ROSEN, A LEADING LAW FIRM, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Secure C...

Newsfile Corp 4/25/2022 AUPH SHAREHOLDER ALERT: ROSEN, A LEADING NATIONAL FIRM, Encourages Aurinia Pharmaceuticals Inc. Inve...

Newsfile Corp 4/22/2022 ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED FIRM, Encourages Aurinia Pharmaceuticals Inc. Investo...

Newsfile Corp 4/20/2022 ROSEN, NATIONAL TRIAL LAWYERS, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Secu...

GlobeNewswire 3/24/2022 AUPH INVESTOR NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Aurinia Pharmaceuticals Inc. Investors w...

GlobeNewswire 3/18/2022 ROSEN, A LEADING LAW FIRM, Encourages Aurinia Pharmaceuticals Inc. Investors With Losses to Inquire ...

GlobeNewswire 3/12/2022 AUPH EQUITY ALERT: ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages Aurinia Pharmaceuticals I...

GlobeNewswire 3/5/2022 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aurinia Pharmace...

GlobeNewswire 9/30/2021 The Lupus Research Alliance Unites Global Community at Immersive Virtual Walk Experience to Support ...

GlobeNewswire 7/15/2021 Oxford Biomedica Appoints Dr. Michael Hayden as Non-Executive Director

GlobeNewswire 6/23/2021 Gritstone Announces Management Changes, Including the Appointment of Celia Economides as Chief Finan...

GlobeNewswire 4/30/2019 Global Chronic Kidney Disease Markets and Technologies Through 2023

GlobeNewswire 4/8/2019 Report: Developing Opportunities within Adverum Biotechnologies, Aurinia Pharmaceuticals, Baytex Ene...

GlobeNewswire 3/5/2019 Kezar Life Sciences Strengthens Management Team, Appoints Celia Economides as Senior Vice President,...

GlobeNewswire 1/30/2019 Factors of Influence in 2019, Key Indicators and Opportunity within Leidos, Nomad Foods, Huron Consu...

GlobeNewswire 11/2/2018 Systemic Lupus Erythematosus - Worldwide Market Analysis by Drug Class and Route of Administration (...

GlobeNewswire 10/3/2018 Robert Foster Appointed Acting Chief Executive Officer of ContraVir Pharmaceuticals, Inc.

GlobeNewswire 8/17/2018 Investor Expectations to Drive Momentum within Natural Resource Partners LP, Insmed, MagnaChip Semic...

Aurinia Pharmaceuticals Inc/ CA05156V1022 /

If you wish to receive reply to your feedback, please provide your email address.